Syntrix Biosystems Inc.
Auburn, WA Syntrix Biosystems Inc.
- UEI
- L5Z8K6ZE8LY4
- CAGE
- 4PR79
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 215 Clay St NW b5, Auburn, WA 98001, USA
- Website
- syntrixbio.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| A dose expansion study of SX-682 alone and in combination with decitabine in MDS patients - myelodysplastic syndromes… | National Cancer Institute | $2,054,540 | |
| A phase 2, single-arm study of the CXCR1/2 inhibitor SX-682 plus enzalutamide in men with abiraterone-resistant… | National Cancer Institute | $4,103,850 | |
| A phase 1 randomized single oral dose four period cross-over study investigating omnitram dose proportionality and… | National Institute on Drug Abuse | $1,649,815 | |
| HLS- a phase 1 open-label dose-escalation with expansion study of SX-682 in MDS patients | National Heart Lung and Blood Institute | $3,398,342 | |
| A phase 1 clinical trial evaluating the novel small molecule immuno-oncology antagonist SX-682 alone and with… | National Cancer Institute | $3,923,707 |
Quick answers
What is Syntrix Biosystems Inc.'s UEI?
Syntrix Biosystems Inc.'s Unique Entity ID (UEI) in SAM.gov is L5Z8K6ZE8LY4.
What is Syntrix Biosystems Inc.'s CAGE code?
Syntrix Biosystems Inc.'s CAGE code is 4PR79.
Where is Syntrix Biosystems Inc. located?
Syntrix Biosystems Inc.'s physical address in SAM.gov is 215 Clay St NW b5, Auburn, WA 98001, USA.
Is Syntrix Biosystems Inc. registered in SAM.gov?
Yes. Syntrix Biosystems Inc.'s SAM.gov registration is active through June 24, 2027.
What is Syntrix Biosystems Inc.'s most recent federal award?
Syntrix Biosystems Inc.'s most recent federal grant award is A dose expansion study of SX-682 alone and in combination with decitabine in MDS patients - myelodysplastic syndromes… (R44CA291622), from National Cancer Institute, on September 16, 2024.
On GovTribe
See Syntrix Biosystems Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors